Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5

Yizhen Tian, Weihu Yang, Ruiying Yang, Qingqing Zhang, Luyang Hao, Enze Bian, Yuquan Yang, Xuewei Huang, Yongjie Wu, Baolai Zhang

Toxicology and Applied Pharmacology · 2021 · 10 citations · 43 references

Concepts

References

43